These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
64. Early human prostate adenocarcinomas harbor androgen-independent cancer cells. Fiñones RR; Yeargin J; Lee M; Kaur AP; Cheng C; Sun P; Wu C; Nguyen C; Wang-Rodriguez J; Meyer AN; Baird SM; Donoghue DJ; Haas M PLoS One; 2013; 8(9):e74438. PubMed ID: 24086346 [TBL] [Abstract][Full Text] [Related]
65. Intermediate basal cells of the prostate: in vitro and in vivo characterization. Garraway LA; Lin D; Signoretti S; Waltregny D; Dilks J; Bhattacharya N; Loda M Prostate; 2003 May; 55(3):206-18. PubMed ID: 12692787 [TBL] [Abstract][Full Text] [Related]
66. Androgen signaling is essential for development of prostate cancer initiated from prostatic basal cells. He Y; Hooker E; Yu EJ; Cunha GR; Liao L; Xu J; Earl A; Wu H; Gonzalgo ML; Sun Z Oncogene; 2019 Mar; 38(13):2337-2350. PubMed ID: 30510232 [TBL] [Abstract][Full Text] [Related]
67. The molecular and cellular origin of human prostate cancer. Packer JR; Maitland NJ Biochim Biophys Acta; 2016 Jun; 1863(6 Pt A):1238-60. PubMed ID: 26921821 [TBL] [Abstract][Full Text] [Related]
68. The Efflux Transporter ABCG2 Maintains Prostate Stem Cells. Sabnis NG; Miller A; Titus MA; Huss WJ Mol Cancer Res; 2017 Feb; 15(2):128-140. PubMed ID: 27856956 [TBL] [Abstract][Full Text] [Related]
69. Infiltrating mast cells enhance prostate cancer invasion via altering LncRNA-HOTAIR/PRC2-androgen receptor (AR)-MMP9 signals and increased stem/progenitor cell population. Li L; Dang Q; Xie H; Yang Z; He D; Liang L; Song W; Yeh S; Chang C Oncotarget; 2015 Jun; 6(16):14179-90. PubMed ID: 25895025 [TBL] [Abstract][Full Text] [Related]
70. Prostate cancer stem cells: do they have a basal or luminal phenotype? Maitland NJ; Frame FM; Polson ES; Lewis JL; Collins AT Horm Cancer; 2011 Feb; 2(1):47-61. PubMed ID: 21761340 [TBL] [Abstract][Full Text] [Related]
71. Knockdown of ZEB1 reverses cancer stem cell properties in prostate cancer cells. Pérez G; López-Moncada F; Indo S; Torres MJ; Castellón EA; Contreras HR Oncol Rep; 2021 May; 45(5):. PubMed ID: 33760173 [TBL] [Abstract][Full Text] [Related]
72. Characterization of nonmalignant and malignant prostatic stem/progenitor cells by Hoechst side population method. Mimeault M; Batra SK Methods Mol Biol; 2009; 568():139-49. PubMed ID: 19582424 [TBL] [Abstract][Full Text] [Related]
73. Hypoxia and Inflammation in Prostate Cancer Progression. Cross-talk with Androgen and Estrogen Receptors and Cancer Stem Cells. Russo MA; Ravenna L; Pellegrini L; Petrangeli E; Salvatori L; Magrone T; Fini M; Tafani M Endocr Metab Immune Disord Drug Targets; 2016; 16(4):235-248. PubMed ID: 27908264 [TBL] [Abstract][Full Text] [Related]
74. A luminal epithelial stem cell that is a cell of origin for prostate cancer. Wang X; Kruithof-de Julio M; Economides KD; Walker D; Yu H; Halili MV; Hu YP; Price SM; Abate-Shen C; Shen MM Nature; 2009 Sep; 461(7263):495-500. PubMed ID: 19741607 [TBL] [Abstract][Full Text] [Related]
75. Context-dependent hormone-refractory progression revealed through characterization of a novel murine prostate cancer cell line. Watson PA; Ellwood-Yen K; King JC; Wongvipat J; Lebeau MM; Sawyers CL Cancer Res; 2005 Dec; 65(24):11565-71. PubMed ID: 16357166 [TBL] [Abstract][Full Text] [Related]
76. Loss of androgen receptor expression promotes a stem-like cell phenotype in prostate cancer through STAT3 signaling. Schroeder A; Herrmann A; Cherryholmes G; Kowolik C; Buettner R; Pal S; Yu H; Müller-Newen G; Jove R Cancer Res; 2014 Feb; 74(4):1227-37. PubMed ID: 24177177 [TBL] [Abstract][Full Text] [Related]
78. The path toward identifying prostatic stem cells. Taylor RA; Risbridger GP Differentiation; 2008 Jul; 76(6):671-81. PubMed ID: 18752495 [TBL] [Abstract][Full Text] [Related]
79. TAp63 and ΔNp63 (p40) in prostate adenocarcinomas: ΔNp63 associates with a basal-like cancer stem cell population but not with metastasis. Galoczova M; Nenutil R; Pokorna Z; Vojtesek B; Coates PJ Virchows Arch; 2021 Apr; 478(4):627-636. PubMed ID: 33037932 [TBL] [Abstract][Full Text] [Related]
80. Methodologies in assaying prostate cancer stem cells. Li H; Jiang M; Honorio S; Patrawala L; Jeter CR; Calhoun-Davis T; Hayward SW; Tang DG Methods Mol Biol; 2009; 568():85-138. PubMed ID: 19582423 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]